KYIV. March 18 (Interfax-Ukraine) – Interchem double liability company (Odesa) took part in the largest pharmaceutical exhibition in Eastern Africa in Kenya, Interchem Head Anatoliy Reder has said in an interview with Interfax-Ukraine.
“I’ve managed to have a fruitful talk with top managers of Kenya’s registration service. These are skilled specialists interested in Ukraine manufacturers’ entrance to the local pharmaceutical market. Considering Ukraine as a part of Europe they hope that the product that we will be able to supply will be of high quality. It will meet European requirements, but it would be cheaper than European alternative products,” Reder said.
He said that the African pharmaceutical market is complicated due to types of distribution, and the Kenyan market is rather weak.
“Tentatively it is annually estimated at some $250 million. The number of the population is comparable with Ukraine. Some $450 million of donor funds is spent on fighting malaria and HIV. The products sold in Kenya have small margins. This means that business is intricate. Some 95% of importers on the Kenyan market are from India. They always are heading to super low prices and unsophisticated products. The market is developing, and shares similar trends with our market,” he said.
He said that after the exhibition Interchem decided to study the issue of entering the African pharmaceutical market.
Interchem double liability company is one of the leading Ukrainian manufacturers of medicine and pharmaceutical substances. It has a full production cycle from the design and synthesis of new biologically active molecules, and the industrial production of pharmaceutical substances, to the production of medicines and sales of products to end consumers.
